Department of Pelvic Cancer, Division of Coloproctology, Karolinska University Hospital, Stockholm, Sweden.
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Colorectal Dis. 2021 May;23(5):1102-1108. doi: 10.1111/codi.15496. Epub 2021 Jan 1.
Approximately 25% of anal cancer patients undergo abdominoperineal excision or more extensive surgery. Following surgery, a high perineal complication rate has been reported. Enhanced recovery after surgery (ERAS) is an evidence-based multimodal interventional programme introduced to mitigate the risk of complications. This study aims to describe perineal healing in relation to ERAS compliance, type of resection and method of perineal reconstruction in patients with anal cancer after salvage surgery.
This is a retrospective cohort study including all patients undergoing abdominal surgery for squamous cell anal cancer in Stockholm between January 2005 and December 2015. Data collection was from registers supplemented by chart review. All patients were followed until death or 1 year after surgery. The associations between ERAS compliance, patient and treatment characteristics and perineal wound healing were evaluated using logistic regression.
In total, 101 patients (67 women) were included, of whom 72 were ERAS compliant. Of patients alive, healing after surgery occurred in 61/98 and 84/89 at 3 months and 1 year, respectively. Perineal healing at 3 months was statistically significantly associated with younger age and type of perineal reconstruction (in favour of vertical rectus abdominis myocutaneous flap). No associations were observed at 1 year but almost all wounds were healed.
Age and type of perineal reconstruction appear to be significantly associated with improved healing at 3 months whereas compliance to an ERAS protocol and type of resection do not. Nearly all patients had a fully healed perineal wound 1 year after surgery for anal cancer.
大约 25%的肛门癌患者需要接受腹会阴切除术或更广泛的手术。手术后,会报告很高的会阴并发症发生率。术后快速康复(ERAS)是一种基于证据的多模式干预方案,旨在降低并发症风险。本研究旨在描述肛门癌患者在挽救性手术后与 ERAS 依从性、切除类型和会阴重建方法相关的会阴愈合情况。
这是一项回顾性队列研究,纳入了 2005 年 1 月至 2015 年 12 月期间在斯德哥尔摩接受腹部手术治疗鳞状细胞肛门癌的所有患者。数据收集来自登记处,并通过病历回顾进行补充。所有患者均随访至死亡或手术后 1 年。使用逻辑回归评估 ERAS 依从性、患者和治疗特征与会阴伤口愈合之间的关系。
共纳入 101 例患者(67 例女性),其中 72 例符合 ERAS 标准。在存活的患者中,术后 3 个月和 1 年时,分别有 61/98 和 84/89 例患者愈合。3 个月时的会阴愈合与年龄较小和会阴重建类型(垂直腹直肌肌皮瓣)显著相关。1 年时未观察到相关性,但几乎所有伤口都愈合了。
年龄和会阴重建类型似乎与 3 个月时的愈合改善显著相关,而 ERAS 方案的依从性和切除类型则没有。几乎所有患者在肛门癌挽救性手术后 1 年均有完全愈合的会阴伤口。